Similar articles

• Statins for patients with type 2 diabetes.

  Pimpinella G, Bertini Malgarini R, Martini N. Pimpinella G, et al. Lancet. 2004 Nov 27-Dec 3;364(9449):1933; author reply 1933. doi: 10.1016/S0140-6736(04)17462-X. Lancet. 2004. PMID: 15566999 No abstract available.
• [CARDS confirms usefulness of LDL lowering in type 2 diabetics].

  Bern VH. Bern VH. Praxis (Bern 1994). 2004 Oct 27;93(44):1 p following 1830. Praxis (Bern 1994). 2004. PMID: 15559908 German. No abstract available.
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators. Colhoun HM, et al. Lancet. 2004 Aug 21-27;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5. Lancet. 2004. PMID: 15325833 Clinical Trial.
• [Statins in diabetic hyperlipidemia].

  Kirchmair R, Sturm W, Gänzer H, Patsch JR. Kirchmair R, et al. Wien Med Wochenschr. 1999;149(5-6):139-43. Wien Med Wochenschr. 1999. PMID: 10408005 Review. German.
• What's in the CARDS?

  Plummer CJ. Plummer CJ. Diabet Med. 2006 Jul;23(7):711-4. doi: 10.1111/j.1464-5491.2006.01903.x. Diabet Med. 2006. PMID: 16842473 Review. No abstract available.